University Hospital Heidelberg
Clinical trials sponsored by University Hospital Heidelberg, explained in plain language.
-
MRI-Guided radiation aims to zap tough lung tumors safely
Disease control OngoingThis early-stage study is testing whether using MRI guidance can allow doctors to safely deliver higher, more effective doses of targeted radiation to lung tumors located very close to critical structures like the windpipe and esophagus. Up to 38 adults with these 'ultracentral' …
Phase: PHASE1 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC
-
Five sessions instead of weeks: new prostate cancer radiation trial
Disease control OngoingThis study is testing whether a much shorter radiation treatment for prostate cancer—just 5 sessions instead of the usual 7-8 weeks—is safe and effective. It uses MRI guidance to precisely target the tumor while aiming to protect surrounding healthy tissue. The main goal is to se…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
MRI scans guide radiation in Real-Time to fight tough lung cancer
Disease control OngoingThis study is testing a new way to deliver radiation therapy for advanced non-small cell lung cancer. It uses real-time MRI scans to guide and adjust the radiation beams during treatment, aiming to target the tumor more precisely while better protecting healthy lung tissue. The g…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC